13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 36 holding rows worth $450,122,000.
- Accession
- 0001172661-22-000487
- Filer
- CIK 1281446
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 36 entries on the cover page, a total value of $450,122,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $450,122,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 530,670 | $49,320,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,750,000 | $31,990,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 950,000 | $29,678,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 800,000 | $24,832,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 592,250 | $20,581,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 85,000 | $18,666,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 864,300 | $16,966,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 300,000 | $16,539,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 717,320 | $16,161,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 1,000,000 | $16,050,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 350,000 | $15,953,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,400,000 | $13,384,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 5,000,000 | $13,250,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 145,405 | $13,094,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 200,000 | $12,174,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 500,000 | $11,895,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 500,000 | $11,885,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 800,000 | $11,632,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 500,526 | $10,926,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 444,443 | $10,618,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 845,000 | $10,047,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 1,518,095 | $9,640,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,121,122 | $8,980,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 873,424 | $8,306,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 390,041 | $6,362,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 536,738 | $6,317,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 1,550,000 | $5,859,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 411,937 | $5,450,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 1,170,000 | $5,183,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 400,000 | $4,388,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 910,251 | $4,324,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 203,900 | $2,755,000 | thousands by filing date | call |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 668,907 | $2,602,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 472,433 | $1,791,000 | thousands by filing date | |
| Rafael Holdings Inc Class B | 75062E106 | COM | 285,714 | $1,457,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 190,520 | $1,067,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-000487 | this filing | 2022-02-14 | acceptance time not in the bulk data set |